Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome

Annals of Hematology

Volumn 84, Issue 12, 2005, Pages 816-822

  Ozelo, Margareth Castro ^a   Svirin, Pavel ^b   Larina, Lubov ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Izmailovskaya Children's Hospital   (Russian Federation)

Author keywords

Bernard Soulier syndrome; Recombinant factor VIIa; rFVIIa

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 9; FRESH FROZEN PLASMA; GLYCOPROTEIN IB ALPHA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RISTOCETIN;

ADOLESCENT; ADULT; ARTICLE; BERNARD SOULIER DISEASE; BLEEDING; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG DOSE REGIMEN; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INTERNET; MENORRHAGIA; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT FAILURE;

6-AMINOCAPROIC ACID; ADOLESCENT; ADULT; ANTIFIBRINOLYTIC AGENTS; BERNARD-SOULIER SYNDROME; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FACTOR VII; FEMALE; HEMOPHILIA A; HUMANS; MENORRHAGIA; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; PLATELET TRANSFUSION; RECOMBINANT PROTEINS;

EID: 29444451700     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1080-y     Document Type: Article

References (41)

1. Abshire T, Kenet G (2004) Recombinant factor VIIa: Review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2:899-909 10.1111/ j.1538-7836.2004.00759.x
2. Aldouri M (2002) The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 32(Suppl 1):41-46 10.1159/000057301
3. Almeida AM, Khair K, Hann I, Liesner R (2003) The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 121:477-481 10.1046/j.1365-2141.2003.04286.x
4. Balduini CL, Iolascon A, Savoia A (2002) Inherited thrombocytopenias: from genes to therapy. Haematologica 87:860-880 12161364
5. Berndt MC, Fournier DJ, Castaldi PA (1989) Bernard-Soulier syndrome. Baillieres Clin Haematol 2:585-607 2550101
6. Bouwmeester FW, Jonkhoff AR, Verheijen RH, van Geijn HP (2003) Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 101:1174-1176 10.1016/ S0029-7844(03)00350-8
7. Ciavarella N, Schiavoni M, Valenzano E, Mangini F, Inchingolo F (1996) Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor. Haemostasis 26(Suppl 1):150-154
8. d'Oiron R, Menart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, Laurian Y, Negrier C (2000) Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost 83:644-647 10823254
9. De Marco L, Mazzucato M, Masotti A, Fenton JW, Ruggeri ZM (1991) Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin. J Biol Chem 266:23776-23783 1748654
10. LC Dunlop RK Andrews MC Berndt 1994 Congenital disorders of platelet function. In: J Loscalzo AI Schafer (eds) Thrombosis and hemorrhage Blackwell Scientific Boston p. 615
11. Dutton RP, Hess JR, Scalea TM (2003) Recombinant factor VIIa for control of hemorrhage: Early experience in critically ill trauma patients. J Clin Anesth 15:184-188 10.1016/S0952-8180(03)00034-5
12. Grossman RE, Geisen U, Schwender S, Keller F (2000) Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with Type III von Willebrand's disease and alloantibodies against von Willebrand factor. Thromb Haemost 83:633-634 10780333
13. Hoffman M, Monroe DM (2001) A cell-based model of hemostasis. Thromb Haemost 85:958-965 11434702
14. Hunault M, Bauer KA (2000) Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost 26:405-405 10.1055/ s-2000-8459
15. Kaleelrahman M, Minford A, Parapia LA (2004) Use of recombinant factor VIIa in inherited platelet disorders. Br J Haematol 125:95-96 10.1111/ j.1365-2141.2004.04878.x
16. Kenet G, Walden R, Eldad A, Martinowitz U (1999) Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354:1879 10.1016/ S0140-6736(99)05155-7
17. Kenny D, Jonsson OG, Morateck PA, Montgomery RR (1998) Naturally occurring mutations in glycoprotein Ibalpha that result in defective ligand binding and synthesis of a truncated protein. Blood 92:175-183 9639514
18. Kenny D, Morateck PA, Gill JC, Montgomery RR (1999) The critical interaction of glycoprotein (GP) IBbeta with GPIX - a genetic cause of Bernard-Soulier syndrome. Blood 93:2968-2975 10216092
19. Kessler C (2004) Haemostasis.com: Clinical experiences in the investigational use of rFVIIa in the management of severe haemorrhage. Br J Haematol 127:230 10.1111/j.1365-2141.2004.05171.x
20. Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U (1996) Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 26(Suppl 1):159-164 8904193
21. Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briet E, Buller HR (1999) Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints. Lancet 354:1940-1947 10.1016/S0140-6736(99)01264-7
22. Locatelli F, Rossi G, Balduini C (2003) Hematopoietic stem-cell transplantation for the Bernard-Soulier syndrome. Ann Intern Med 138:79 12513061
23. Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC (1998) Bernard-Soulier syndrome. Blood 91:4397-4418 9616133
24. Margaglione M, D'Andrea G, Grandone E, Brancaccio V, Amoriello A, Di Minno G (1999) Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib alpha gene in a patient with a severe bleeding tendency. Thromb Haemost 81:486-492 10235425
25. Mariani G, Testa MG, Di Paolantonio T, Molskov BR, Hedner U (1999) Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies. Vox Sang 77:131-136 10.1159/000031091
26. Martinowitz U, Kenet G, Lubetsky A, Segal E (2002) Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anaesth 49:S15-S20 12546003
27. Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, Lynn M (2001) Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51:431-439 11535886
28. Meijer K, Peters FT, van der Meer J (2001) Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa. Blood Coagul Fibrinolysis 12:211-213 10.1097/00001721-200104000-00008
29. Monroe DM, Roberts HR (2003) Mechanism of action of high-dose factor VIIa: Points of agreement and disagreement. Arterioscler Thromb Vasc Biol 23:8-9 10.1161/01.ATV.0000047645.37970.AB
30. Moran N, Morateck PA, Deering A, Ryan M, Montgomery RR, Fitzgerald DJ, Kenny D (2000) Surface expression of glycoprotein Ib alpha is dependent on glycoprotein Ib beta: Evidence from a novel mutation causing Bernard-Soulier syndrome. Blood 96:532-539 10887115
31. Moscardo F, Perez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA (2001) Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 114:174-176 10.1046/j.1365-2141.2001.02878.x
32. Naik VN, Mazer CD, Latter DA, Teitel JM, Hare GM (2003) Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass. Can J Anaesth 50:599-602 12826554
33. Peters M, Heijboer H (1998) Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost 80:352 9716174
34. Poon MC, d'Oiron R (2000) Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International registry on recombinant factor VIIa and congenital platelet disorders group. Blood Coagul Fibrinolysis 11(Suppl 1):S55-S68 10850567
35. Poon MC, Demers C, Jobin F, Wu JW (1999) Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 94:3951-3953 10572113
36. Seremetis S (2003) Dose optimization of recombinant factor VIIa in the treatment of acute bleeding in haemophilia-associated inhibitors. Blood Coagul Fibrinolysis 14(Suppl 1):S29-S30 10.1097/00001721-200306001-00007
37. Sobieszczyk S, Breborowicz GH, Markwitz W, Mallinger S, Adamski D, Kruszynski Z (2002) Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy. Ginekol Pol 73:230-233 12092258
38. Tanaka KA, Waly AA, Cooper WA, Levy JH (2003) Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology 98:1513-1515 10.1097/ 00000542-200306000-00034
39. van Buuren HR, Wielenga JJ (2002) Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia. Dig Dis Sci 47:2134-2136 10.1023/A:1019605803467
40. Waldenstrom E, Holmberg L, Axelsson U, Winqvist I, Nilsson IM (1991) Bernard-Soulier syndrome in two Swedish families: Effect of DDAVP on bleeding time. Eur J Haematol 46:182-187 1901273
41. Zupancic SS, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M (2002) Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome. Acta Haematol 108:162-163 10.1159/000064699